HIGHLIGHTS
- who: MDPI from the Korea Institute National University have published the research: Type of the Paper (Article, in the Journal: (JOURNAL) of 13/07/2022
- future: A broader perspective of the immune system and the dynamic changes of immune factors is thus required.
SUMMARY
Biomarkers are molecular characteristics of a disease that can be used to help make decisions about treatment. Through the recognition of novel biomarkers, it has become possible to identify subsets of patients who benefit from specific targeted therapies. The success of targeted anticancer therapies and new immunotherapeutic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.